Biosplice Therapeutics is in the medical research and development for tissue-level regeneration. With their platform's origins in small molecule-based Wnt pathway modulation, they develop therapeutics to address a range of degenerative diseases, regenerative medicine, and oncology.Samumed adopted a fresh operating philosophy from thebeginning — one based on a goal of building a broad technology platform aimed at modulating regenerative pathways to improve patient health.

Biotechnology

Health Care

Biosplice Therapeutics

Cevdet Samikoglu

SAM NAMIQ

Scott Bulcao

Osman Kibar

John Hill

Jeymi Tambiah

Erich Horsley

Christopher Swearingen

The Clinical Operations team at Biosplice Therapeutics manages and oversees the execution of clinical trials, ensuring compliance with regulatory guidelines and protocols. They coordinate between various departments to optimize trial design, implementation, data collection, and analysis, thereby supporting the development of therapeutic solutions for degenerative diseases, regenerative medicine, and oncology.

Clinical Operations

Leadership Team

Research and Development

Clinical Operations

About

Team members

Other teams at Biosplice Therapeutics

Leadership Team

Research and Development